{"url_path":"/fda/drug/recalls/D-0483-2026","section_key":"summary","section_title":"DRUG Recall: International Medication Systems Ltd. — EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICATION SYSTEMS, LIMITED, So. EL Monte, CA 91733, An Amphastar Pharmaceutical Company, NDC 76329-3318-1","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-01","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0483-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"International Medication Systems Ltd."},"word_count":71,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0483-2026\n\n**Recalling firm:** International Medication Systems Ltd.\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-01\n**Report date:** 2026-04-22\n\n## Product\nEPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICATION SYSTEMS, LIMITED, So. EL Monte, CA 91733, An Amphastar Pharmaceutical Company, NDC 76329-3318-1\n\n## Reason\nLack of Assurance of Sterility\n\n## Affected lots\nLot Number: EA038A5, Expiration Date: 08/2026.\n\n## Distribution\nU.S. Nationwide"}